Can Levothyroxine Cause Anxiety?

How Levothyroxine Affects the Nervous System

Levothyroxine is synthetic thyroxine (T4). The body converts it to triiodothyronine (T3), the active form that binds nuclear receptors throughout the brain and peripheral nervous system. When circulating T3 rises above physiological range, it increases sympathetic nervous system tone, raises heart rate, and accelerates neuronal firing in ways that directly produce anxiety symptoms.

The FDA-approved prescribing information for levothyroxine explicitly lists "nervousness, anxiety, irritability, emotional lability" as adverse reactions associated with excessive dosing [1]. This is not a rare or theoretical concern; it is a documented pharmacological effect.

The Sympathomimetic Cascade

Excess thyroid hormone up-regulates beta-adrenergic receptors, amplifying the body's response to its own adrenaline. The result is a state that feels indistinguishable from a panic response: heart pounding, sweating, trembling hands, a sense of dread. Beta-blockers such as propranolol 10 to 40 mg are sometimes used short-term to blunt these symptoms while the levothyroxine dose is being recalibrated [2].

Central Nervous System Effects

Thyroid hormone influences serotonin receptor density and catecholamine turnover in the brain. A 2018 review in Frontiers in Endocrinology found that both hypothyroid and hyperthyroid states alter serotonergic and noradrenergic signaling, explaining why mood and anxiety disorders cluster at both ends of the thyroid spectrum [3]. Too little hormone and too much hormone can each destabilize mood, which is why the direction of the TSH shift matters as much as the presence of symptoms.

Distinguishing Over-Replacement from Under-Treatment

This is the most clinically significant question a prescriber must answer when a patient on levothyroxine reports new anxiety. The two causes require opposite interventions.

Over-Replacement (Dose Too High)

When levothyroxine is dosed too aggressively, TSH falls below the lower reference limit (typically <0.5 mIU/L). Associated symptoms include:

• Anxiety and irritability
• Palpitations or atrial fibrillation
• Heat intolerance and excessive sweating
• Unintended weight loss
• Insomnia and tremor

A 2019 population study published in The Journal of Clinical Endocrinology and Metabolism (N=5,912) found that patients with suppressed TSH (<0.1 mIU/L) on levothyroxine had a significantly higher prevalence of self-reported anxiety and cardiac arrhythmia compared with those in the normal TSH range [4]. Dose reduction is the correct response.

Under-Treatment (Dose Too Low)

Paradoxically, inadequately treated hypothyroidism also produces anxiety. Low T3 in the brain disrupts GABAergic inhibition and raises circulating cortisol, creating a low-grade hyperarousal state. The American Thyroid Association 2014 guidelines note that psychiatric symptoms, including anxiety, are well-recognized features of hypothyroidism itself and may not resolve until TSH normalizes [5].

A patient whose TSH is 8.0 mIU/L while on levothyroxine is still hypothyroid. Increasing the dose, not reducing it, is the right move in that scenario.

The TSH Test as the Decision Point

TSH is the single most useful test for sorting out the cause of anxiety in someone taking levothyroxine [5]. Draw the TSH before any dose change. The result tells you which direction to go.

| TSH Result | Interpretation | Recommended Action | |---|---|---| | <0.5 mIU/L | Over-replacement | Reduce dose by 12.5 to 25 mcg | | 0.5 to 2.5 mIU/L | Therapeutic range | Investigate other anxiety causes | | 2.5 to 4.5 mIU/L | High-normal, possibly under-treated | Consider modest dose increase | | >4.5 mIU/L | Under-replacement | Increase dose |

What the Research Actually Shows

Anxiety Prevalence in Hypothyroidism

Before treatment begins, anxiety is common in hypothyroid patients. A 2020 cross-sectional study in Thyroid (N=3,287) found that 63% of patients with newly diagnosed hypothyroidism met screening criteria for clinically significant anxiety on the GAD-7 scale [6]. Many of these patients expected their symptoms to resolve entirely once levothyroxine was started. For a significant subset, they did not, at least not immediately.

T4 Monotherapy and Residual Symptoms

Not every patient feels well on levothyroxine alone. T4-to-T3 conversion varies by individual genetics, gut health, and selenium status. Some patients with normal TSH continue to report anxiety, fatigue, and cognitive symptoms. A 2019 randomized controlled trial in The Lancet Diabetes and Endocrinology (N=552) compared T4 monotherapy with a combination of T4 plus T3 (liothyronine) and found that roughly 15% of patients had a preference for the combination, often citing mood and anxiety outcomes [7]. The trial did not show a statistically significant group-level benefit for T4 plus T3, but the subset data suggest that conversion efficiency matters for some individuals.

Subclinical Hyperthyroidism and Psychiatric Risk

Suppressed TSH even without overt hyperthyroid symptoms carries psychiatric risk. A Danish nationwide cohort study published in JAMA Internal Medicine (N=222,829) found that individuals with a TSH below 0.1 mIU/L had a hazard ratio of 1.48 (95% CI 1.28 to 1.71) for being diagnosed with an anxiety disorder within five years, compared with euthyroid controls [8]. Levothyroxine over-replacement is a modifiable contributor to this risk.

Specific Populations at Higher Risk for Levothyroxine-Induced Anxiety

Older Adults

Adults over 65 are more sensitive to supratherapeutic thyroid hormone levels. The American Geriatrics Society recommends a TSH target of 1.0 to 3.0 mIU/L for older adults and cautions against TSH suppression in this group because of heightened cardiovascular and neuropsychiatric risk [9]. Small dose adjustments, often 12.5 mcg increments, are preferred in this population.

Women in Perimenopause

Estrogen influences thyroid-binding globulin levels, which affects how much free T4 circulates. Women entering perimenopause may find their levothyroxine requirement shifts. A dose that was stable for years can become relatively excessive as estrogen levels fluctuate, driving TSH down and triggering anxiety symptoms that are easy to misattribute to hormonal change alone. Annual TSH monitoring is the minimum standard; twice-yearly checks make sense during active perimenopause [5].

Patients With Pre-Existing Anxiety Disorders

Patients who already carry a diagnosis of generalized anxiety disorder or panic disorder have a lower physiological threshold for catecholamine-mediated arousal. Even a TSH that sits at the low end of normal (0.5 to 1.0 mIU/L) may produce noticeable anxiety in this group. Some clinicians aim for a slightly higher TSH target, around 1.5 to 2.5 mIU/L, in this population, though this must be balanced against ensuring adequate thyroid replacement.

Drug and Supplement Interactions That Worsen Anxiety

Levothyroxine absorption and metabolism are affected by multiple compounds. When absorption increases unexpectedly, effective dose rises and anxiety can follow.

Common Interacting Substances

• Calcium carbonate and iron supplements: Taken within four hours of levothyroxine, these bind T4 in the gut and reduce absorption. Separating them by at least four hours is the standard recommendation [1].
• Cholestyramine and colestipol: These bile-acid sequestrants reduce T4 absorption by up to 35%. Patients switching to or from these agents need TSH monitoring within six to eight weeks [1].
• Rifampicin and phenytoin: These enzyme inducers accelerate T4 clearance, typically raising the levothyroxine dose requirement. Stopping these drugs without adjusting levothyroxine can result in relative over-replacement and anxiety.
• Caffeine: High caffeine intake does not directly interact with levothyroxine metabolism, but caffeine amplifies the sympathomimetic effects of excess thyroid hormone. Patients reporting anxiety on levothyroxine should be asked about caffeine load before any dose change is made.
• Sertraline and other SSRIs: Some SSRIs increase thyroid hormone clearance modestly. Starting an SSRI for anxiety in a hypothyroid patient may paradoxically worsen TSH control if levothyroxine dose is not adjusted [1].

Formulation Differences and Anxiety

Brand vs. Generic Levothyroxine

The FDA requires generic levothyroxine products to be bioequivalent to brand-name products, but the acceptable bioequivalence window is 80% to 125% of the reference product's area under the curve. For most patients this range is clinically irrelevant. For thyroid-sensitive individuals, switching between manufacturers can shift TSH by enough to produce symptoms, including anxiety [1].

If a patient's anxiety coincides with a pharmacy change in levothyroxine manufacturer, checking TSH within four to six weeks is reasonable.

Tirosint (Liquid Gel Cap Formulation)

Tirosint, a gel-capsule formulation of levothyroxine, eliminates fillers and dyes and is absorbed more completely than standard tablets. Patients switching from a standard tablet dose to an equivalent Tirosint dose sometimes experience a functional dose increase, with anxiety as a presenting symptom. The FDA has approved Tirosint specifically for patients with absorption issues, but dose may need to be reduced by 10 to 15% when transitioning [1].

Practical Steps When Levothyroxine Is Causing Anxiety

1. Draw TSH and free T4. Do not change the dose before you have a result. Anxiety has multiple causes; the lab tells you which direction to go.
2. Hold the morning dose on the day of the blood draw. Taking levothyroxine two to three hours before the draw transiently elevates free T4 by 10 to 20% and can falsely suggest over-replacement.
3. If TSH is suppressed, reduce the dose by 12.5 to 25 mcg. Recheck TSH in six to eight weeks.
4. Ask about recent formulation changes. A switch in manufacturer or moving to Tirosint warrants a TSH check.
5. Review the full medication and supplement list. Stopping a T4-binding supplement (calcium, iron) without realizing it can raise effective dose.
6. Consider short-term propranolol. Propranolol 10 mg two to three times daily can reduce palpitations and tremor while waiting for TSH to normalize after a dose reduction [2].
7. Recheck TSH six to eight weeks after any dose change. Levothyroxine has a half-life of approximately seven days; steady state takes five half-lives, roughly five to six weeks, to establish [1].
8. If TSH is normal and anxiety persists, investigate other causes. Normal TSH on levothyroxine with persistent anxiety warrants evaluation for panic disorder, GAD, ADHD, cardiovascular disease, or other contributing factors.

When Anxiety on Levothyroxine Is an Emergency

Most cases of levothyroxine-related anxiety are dose-management problems, not emergencies. Seek urgent care if any of the following occur:

• Heart rate sustained above 120 beats per minute at rest
• Chest pain or pressure
• Irregular heartbeat with lightheadedness
• Fever above 38.5 C combined with agitation (possible thyroid storm, rare but life-threatening)
• Seizure

Thyroid storm is rare in the context of levothyroxine overdose but has been reported in accidental ingestion of very large doses, particularly in children [1]. Emergency management follows standard thyrotoxicosis protocols, including IV propranolol, hydrocortisone, and PTU or methimazole.

Does Levothyroxine Cause Anxiety in People with Normal Thyroid Function?

Some patients are prescribed levothyroxine for thyroid nodules, thyroid cancer surveillance, or obesity, uses that are either investigational or explicitly outside the labeled indication. When levothyroxine is given to someone with an intact thyroid, endogenous production suppresses, but TSH suppression is still a risk.

Levothyroxine is not approved for weight loss in euthyroid individuals. The FDA prescribing information explicitly warns that thyroid hormones should not be used in euthyroid patients for obesity management because of serious or life-threatening toxicity at doses producing weight loss [1]. Anxiety is one of the early warning signs in this misuse scenario.